Aspen Pharmacare In Talks to Buy Merck & Co. Dutch Unit

Aspen Pharmacare Holdings Ltd., South Africa’s largest generic drugmaker, said it’s in talks on a possible acquisition of Dutch ingredient manufacturing capacity and product lines from U.S. medicine producer Merck & Co.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.